1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Flushing: new trials by email Literature Review of Flushing trials Research Report on Flushing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome Octreotide LAR - Neuroendocrine Carcinoma | Phase 2 | Terminated | H. Lee Moffitt Cancer Center and Research Institute | 2 | 2013-12-01 | 2015-01-12 |
Carcinoma, Neuroendocrine (1) · Diarrhea (1) · Neoplasm Metastasis (1) · Neuroendocrine Tumors (1)
Adenocarcinoma (1) · Carcinoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplastic Processes (1) · Neuroectodermal Tumors (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Skin Manifestations (1)
H. Lee Moffitt Cancer Center and Research Institute (1)
United States (1)